Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Disease

Alzheimer’s most prevalent in US east and south-east, first-of-its-kind study finds

Study, which used cognitive data and population estimates, examines prevalence of the disease by county

The Guardian - US

Alzheimer’s rates highest in Texas border counties, new study shows

Texas’ border counties have higher rates of Alzheimer’s disease among older adults than other areas in the state, according to a new study estimating county-level prevalence of the neurodegenerative disease.

Tribune News Service

Excessive drinking during the pandemic increased alcoholic liver disease death rates

Excessive drinking during the covid-19 pandemic increased alcoholic liver disease deaths so much that the condition killed more Californians than car accidents or breast cancer, a KFF Health News analysis has found.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Deadly tickborne virus that’s spreading in Europe ‘likely to reach UK’

Climate change is causing infectious ticks to move north in Europe, expert warns

The Independent UK

FDA approves RSV shot for infants

Beyfortus should be available this fall and can prevent a disease that kills around 300 children per year

Salon

Why Josiah Harrell feels lucky (not sorry) after rare brain disease discovery canceled first UFC fight

A lot of things had to fall in line perfectly for Josiah Harrell to avoid a potentially life-threatening medical event.

USA Today Sports Media Group

Lilly applies for Alzheimer’s drug’s US approval after trial success

Eli Lilly & Co. said it applied for full U.S. approval of its Alzheimer’s disease drug that’s expected to compete with Eisai Co.’s Leqembi as the U.S. drugmaker revealed details of a final-stage trial at a conference in Amsterdam.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Why is this Alzheimer’s breakthrough so important?

Your questions answered on donanemab.

The Independent UK

New drug found to slow Alzheimer’s hailed as turning point

Donanemab has been found to slow down the disease in a clinical trial.

The Independent UK

Everything we know about breakthrough Alzheimer’s drug Donanemab

Alzheimer’s disease is the most common cause of dementia in the UK

The Independent UK

Rheumatic heart disease in Indigenous children could be spread by throat bacteria, researchers find

Exclusive: strep A genome sequencing by Australian scientists will likely have implications for prevention and vaccine development

The Guardian - AU

Vaping Raises Cardiovascular Disease Risk, Study Finds

New research shows vaping increases risk of cardiovascular disease, delivering potentially harmful chemicals to the body.

Zenger

Alzheimer’s: ‘Turning point’ in fight against disease as drug found to slow decline by up to 35%

Experts say ‘we’re entering a new era where Alzheimer’s disease could become treatable’

Evening Standard

‘Turning point’ in the fight against Alzheimer’s as drug found to slow disease

The results of a new trial were labelled as symbolic of ‘a new era where Alzheimer’s disease could become treatable’

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

An experimental Alzheimer's drug outperforms one just approved by the FDA

In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.

The Guardian - UK

What impact will Alzheimer’s drug donanemab have?

While it is not a cure, proof that drugs can alter course of disease is regarded as significant triumph

The Guardian - UK

Experts urge health regulators to approve ‘turning point’ dementia drugs

Exclusive: As results show 35% slowing in cognitive decline, health leaders say swift decisions crucial

The Independent UK

‘Turning point in the fight against Alzheimer’s’ as drug found to slow disease

Donanemab has been found to slow down the disease in a clinical trial.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Young woman diagnosed with ‘suicide disease’ faces race against time: ‘I’m being burned alive’

Desperate mother fighting to save her daughter’s life clinging on to ‘one last hope’

AAP

Free flu jabs as premier tells anyone sick to stay home

Queenslanders will get free flu jabs with the state already recording more cases than last year as concerns grow about the disease spreading among children.

Newcastle Herald

$800k grant helps researchers fight heart disease in cancer patients

'Heart disease disproportionally affects people with cancer'

Tribune News Service

San Diego hospital seeing an alarming number of children 5 and under with cannabis poisoning

San Diego County's only children's hospital reports that it continues to see elevated numbers of young patients arriving in its emergency department with cannabis poisoning, echoing findings from a new analysis released last week by the U.S. Centers for Disease Control and Prevention.

The Guardian - UK

Should I worry about ticks?

Evidence suggests their numbers could be increasing – with bites transmitting viral, bacterial and potentially life-threatening diseases. But there are ways to guard against these attacks

Chicago Sun-Times

Dear Abby: Some relatives never visited my father with Alzheimer’s

Disappointed reader concludes that either they didn’t care, no one cared, or they were for some reason afraid to see someone with the disease

Inverse

This Disease Was The World’s Deadliest Infection Before Covid-19 — Now It's Back

Tuberculosis is on the rise for the first time in decades after Covid-19 interrupted public health interventions and increased inequality.

1 … 314 315 316 317

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Newcastle

Alzheimer Research UK

Eli Lilly and Company

60 stories

JAMA

43 stories

the Alzheimer Association

39 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.